Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/74407
Title: | Primary frontal sinus squamous cell carcinoma in three dogs treated with piroxicam combined with carboplatin or toceranib | Authors: | de Vos, J. Ramos Vega, Sara Noorman, E. de Vos, P. |
UNESCO Clasification: | 310907 Patología 320713 Oncología |
Keywords: | Para-Nasal Sinuses Radiation-Therapy Paranasal Sinuses Neck-Cancer Head, et al |
Issue Date: | 2012 | Journal: | Veterinary and Comparative Oncology | Abstract: | In human medicine, primary frontal sinus squamous cell carcinoma (pFS-SCC) is not frequently reported. In veterinary medicine, frontal sinus SCC is exclusively described as an extension of nasal cavity SCC. To our knowledge, this is the first publication concerning canine pFS-SCC, diagnosed using histology or cytology and medical imaging, in three dogs. The tumours extended into the orbit or brain cavity, without nasal involvement. Treatment was initiated with piroxicamcarboplatin. Prolongation of carboplatin delivery with a low dose intensity was performed on dogs with a favourable initial response. Dog 1 achieved a complete remission (CR), but was euthanized 344 days after start of therapy. Dog 2, still alive 3 years after start of therapy and in CR, received 14 carboplatin deliveries. In dog 3, after changing the treatment protocol into piroxicamtoceranib, a significant tumour reduction occurred, but the dog was euthanized after 195 days because of a relapse. | URI: | http://hdl.handle.net/10553/74407 | ISSN: | 1476-5810 | DOI: | 10.1111/j.1476-5829.2011.00292.x | Source: | Veterinary And Comparative Oncology [ISSN 1476-5810], v. 10 (3), p. 206-213, (Septiembre 2012) |
Appears in Collections: | Artículos |
SCOPUSTM
Citations
23
checked on Nov 24, 2024
WEB OF SCIENCETM
Citations
16
checked on Nov 24, 2024
Page view(s)
162
checked on Jan 27, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.